Nutex Health Inc. has responded to a recent short seller report issued by Capybara Research, stating that the allegations are based on outdated, inapplicable, incomplete, or incorrect information. The company emphasized that Capybara Research appears not to exist as a legitimate entity and that similar lawsuits against it have been unsuccessful due to its concealed identity and location. Nutex Health described the report as an attempt to create market confusion and profit from a decline in its stock price, a tactic it says is commonly used against public companies. The company also stated that it does not intend to comment further on the short seller report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA34279) on November 26, 2025, and is solely responsible for the information contained therein.